Supernus Pharmaceuticals, Inc. (SUPN)
48.30
+1.02
(+2.16%)
USD |
NASDAQ |
Dec 16, 16:00
48.30
0.00 (0.00%)
After-Hours: 20:00
Supernus Pharmaceuticals Accounts Payable (Quarterly): 8.177M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Biogen, Inc. | 413.10M |
| BridgeBio Pharma, Inc. | 18.70M |
| CorMedix, Inc. | 20.45M |
| Assembly Biosciences, Inc. | 1.683M |
| Viking Therapeutics, Inc. | 4.413M |